UGT1A1 and chronic kidney disease: However, no significant effects were found between drug pharmacokinetics and the following characteristics: mild/moderate/severe and even chronic renal insufficiency (RI) [30,32], age, sex, baseline albumin level, race, ECOG status, solid tumor type, UGT1A1 genotype, and Trop 2 expression level [32].